Insider · CIK 0001839697
Andrew Obenshain
Files at BLUE (bluebird bio, Inc.). First filing Dec 12, 2024, latest Dec 12, 2024.
Andrew Obenshain files SEC Form 4 as CEO, president and director at BLUE (bluebird bio, Inc.). Since Dec 12, 2024, Andrew Obenshain has reported 0 open-market buys worth $0 and 1 open-market sell worth $405, the latest filed on Dec 12, 2024.
A track record needs three past buys with six months of prices behind them; Andrew Obenshain has 0, so none is measured yet.
The newest scored trade: sold $405 of BLUE on Dec 10, 2024, filed Dec 12, 2024, scored 13 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | bluebird bio, Inc. | $405 971 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 3, 2025 | BLUE bluebird bio, Inc. | 921 0.01% of outstanding | $3,604 | Mar 3, 2025 | $2,335 |
| Feb 3, 2025 | BLUE bluebird bio, Inc. | 86 0.00% of outstanding | $665 | Feb 3, 2025 | $1,699 |
| Jan 6, 2025 | BLUE bluebird bio, Inc. | 140 0.00% of outstanding | $1,223 | Jan 6, 2025 | $405 |
| Dec 10, 2024 | BLUE bluebird bio, Inc. | 971 0.00% of outstanding | $437 | Dec 10, 2024 | $18k |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | BLUE bluebird bio, Inc. | UTender of shares Common Stock | -9,027 | - | - | 9,300 | Jun 3, 2025 |
| Jun 2, 2025 | BLUE bluebird bio, Inc. | DDisposition to issuer Common Stock | -9,300 | - | - | 0 | Jun 3, 2025 |
| Jun 2, 2025 | BLUE bluebird bio, Inc. | AGrant or award Common Stock | +14,820 | - | - | 14,820 | Jun 3, 2025 |
| Jun 2, 2025 | BLUE bluebird bio, Inc. | DDisposition to issuer Common Stock | -14,820 | - | - | 0 | Jun 3, 2025 |
| Dec 10, 2024 | BLUE bluebird bio, Inc. | SOpen-market sale Common Stock10b5-1 | -971 | $0.42 | $405 | 374,247 | Dec 12, 2024 |
Questions about Andrew Obenshain
Answered from the filings on this page, as of the latest one.
Is Andrew Obenshain buying or selling?
Not in the last 12 months. Andrew Obenshain's latest open-market trade on SEC Form 4 was sold $405 of BLUE on Dec 10, 2024.
How did Andrew Obenshain's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew Obenshain has 0.
Where does Andrew Obenshain file Form 4?
Andrew Obenshain has filed Form 4 at BLUE (bluebird bio, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.